Has Larisa Ravitskiy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,523 in general payments to Larisa Ravitskiy, MD across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Larisa Ravitskiy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Larisa Ravitskiy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Larisa Ravitskiy, MD

MOHS-Micrographic Surgery · New Albany, OHNPI 1144230905

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.7% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $731 and has fallen 52.8% since, to $345 in 2025.

$2,523in general payments, 2019–2025

Across 82 payments — averaging $30.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$568
Sun Pharmaceutical Industries Inc.$542
Johnson & Johnson$326
Organogenesis Inc.$298
Biofrontera Inc.$184
Galderma Laboratories, L.p.$164
plus $440 from 13 others

What the payments were for

Food & beverage$2,33893%
Education$1857%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	18	$568
Sun Pharmaceutical Industries Inc.	15	$542
Johnson & Johnson	12	$326
Organogenesis Inc.	8	$298
Biofrontera Inc.	6	$184
Galderma Laboratories, L.p.	5	$164
Journey Medical Corporation	1	$103
Lilly USA, LLC	2	$61
Ortho Dermatologics, A Division Of Bausch Health US, LLC	3	$51
Sanofi	2	$36
Genentech USA, Inc.	2	$34
E.r. Squibb & Sons, L.L.C.	1	$30
Merz North America, Inc.	1	$24
LEO Pharma Inc.	1	$23
Arcutis Biotherapeutics, Inc.	1	$18
Pfizer	1	$17
AbbVie	1	$16
Stemline Therapeutics Inc.	1	$15
UCB, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ILUMYA$236
LIBTAYO$121
Exelderm$103
Targadox$103
Ximino$103
NuShield$102

How this compares

$2,523 in reported general payments places this provider in the 70th percentile of 35 mohs-micrographic surgery providers in Ohio.

See all mohs-micrographic surgery providers in Ohio →

Medicare billing

Part B allowed, 2024

$273,198

Medicare patients

260

Services billed

6,988

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	11	$40,384
Metronidazole	72	$3,823
Azelaic Acid	18	$1,752
Clobetasol Propionate	40	$1,406
ValacyclovirValacyclovir Hcl	55	$1,120
Ketoconazole	74	$970
Ammonium Lactate	65	$896
Doxycycline Hyclate	25	$740
Hydroxychloroquine Sulfate	12	$684
Dexamethasone	11	$224
Triamcinolone Acetonide	29	$200
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	38	$122
Mupirocin	17	$95
Hydroxyzine Hcl	13	$69
Hydrocortisone	13	$55

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in New Albany

Jorge Garcia ZuazagaConcord Township$149K
Morgan HottWarren$16K
Jennifer PopovskyMedina$15K
Justin WoodhouseMayfield Heights$7K
Mihir ShahWestlake$5K
Allison MoosallyFairlawn$5K
Kathleen NemerAthens$3K
Abdel Kader TalPerrysburg$3K
Patrick KillianWestlake$3K
Alison DurhamCanton$3K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →